Skanska to build Pfizer's new Swedish office for SEK 500 M

Skanska to build Pfizer's new Swedish office for SEK 500 M Skanska has been contracted to build the new office in Sweden for the Pfizer pharmaceuticals company in Sollentuna, a Stockholm suburb. Valued at SEK 500 M, the contract is included in order bookings for the first quarter of 2004. With 31,000 square meters of space, the office building will be one of the largest office projects started in the Stockholm region in recent years. Work will begin in the near future and is expected to be completed for occupancy by the year-end 2005. "We are building an office that will be a natural meeting place for the parties active in Swedish health and medical care. In collaboration with the architects, the employees have been involved in designing the premises and the interior fittings. It will be an office characterized by openness and communications," says Lars Gunneflo, President of Pfizer in Sweden. "Naturally, it is very pleasing to begin such a large office project after the period of weak demand for office premises. We believe that Pfizer's decision to select the Silverdal area will attract more companies to invest here," says Jimmy Bengtsson, Business Manager, Skanska Sweden. The building comprises 18,000 square meters of office space and 13,000 square meters of parking and other space. It is being constructed in the new Silverdal area of Sollentuna, where Skanska and the JM construction company are planning a science park, with offices and residential housing in natural surroundings. Pfizer, one of the world's largest pharmaceutical companies, is a recurring Skanska customer. Skanska recently completed Pfizer's office in Finland in Helsinki. This contract was valued at EUR 20 M, about SEK 180 M. Between 2000 and 2002, Skanska completed a number of projects at Pfizer's facilities in the US. Skanska also constructed Pfizer's current Swedish office in Stockholm. For further information please contact: Anders Danielsson, Vice President, Skanska Sweden, tel +46 8 504 355 43 Ann-Sofi Sjöberg, Information Manager, Pfizer Sweden, tel +46 70 850 63 47 Peter Gimbe, Press Officer, Skanska AB, tel +46 8 753 88 38 This and previous releases can also be found at ------------------------------------------------------------ This information was brought to you by Waymaker The following files are available for download:

About Us

Skanska is one of the world’s leading construction and project development companies, focused on selected home markets in the Nordic region, Europe and USA. Supported by global trends in urbanization and demographics, and by being at the forefront in sustainability, Skanska offers competitive solutions for both simple and the most complex assignments, helping to build a sustainable future for customers and communities. The Group has about 38,000 employees. Skanska's sales in 2018 totaled SEK 170 billion.


Documents & Links